Respiratory Medication Adherence in Chronic Lung Disease of Prematurity

被引:14
|
作者
Collaco, J. Michael [1 ]
Kole, Amanda J. [1 ]
Riekert, Kristin A. [1 ]
Eakin, Michelle N. [1 ]
Okelo, Sande O. [1 ]
McGrath-Morrow, Sharon A. [1 ]
机构
[1] Johns Hopkins Med Inst, Eudowood Div Pediat Resp Sci, Baltimore, MD 21287 USA
关键词
bronchopulmonary dysplasia; chronic lung disease; preterm; prematurity; adherence; compliance; health beliefs; INNER-CITY CHILDREN; BRONCHOPULMONARY DYSPLASIA; CYSTIC-FIBROSIS; ASTHMA; MORBIDITY; BARRIERS; BELIEFS; THERAPY; INFANTS; IMPACT;
D O I
10.1002/ppul.21547
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Chronic lung disease of prematurity (CLDP) is a frequent complication of premature birth. Infants and children with CLDP are often prescribed complex medication regimens, which can be difficult for families to manage. Objective: We sought to determine whether non-adherence was associated with increased CLDP-related morbidities and to identify predictors of adherence. Methods: Recruited caregivers of 194 children with CLDP completed questionnaires regarding self-reported adherence, respiratory outcomes, and quality of life (January 2008-June 2010). Adherence data were available for 176 subjects, of whom 143 had self-reported data only, and 33 had prescription claims data, which were used to calculate a medication possession ratio (MPR). Participants in the Prescription Claims Sample (n = 33) were more likely to have public insurance ( P < 0.001). Results: Self-reported adherence substantially overestimated medication possession; the mean MPR was 38.8% (n = 33) and was not associated with self-reported adherence (P = 0.71; n = 26). In a small sample, higher MPR was associated with decreased odds ratios of visiting the emergency department (ED) (OR = 0.75 for a 10% increase in MPR [95% CI: 0.58, 0.97]; P 0.03; n = 74 questionnaires from 28 participants), activity limitations (OR = 0.71 [95% CI: 0.53, 0.95]; P = 0.02; n = 70 questionnaires from 28 participants), and rescue medication use (OR = 0.84 [95% CI: 0.73-0.98]; P = 0.03; n = 70 questionnaires from 28 participants). Increasing caregiver worries regarding medication efficacy and side effects were associated with lower MPR (P = 0.04 and 0.02, respectively; n = 62 questionnaires from 27 participants). Socio-demographic and clinical risk factors were not predictors of MPR (n = 33). Conclusions: We found that non-adherence with respiratory medications was common in premature infants and children with CLDP. Using multiple timepoints in a small sample, non-adherence was associated with a higher likelihood of respiratory morbidities. Although self-reported adherence and demographic characteristics did not predict MPR, concerns about medications did. We suggest that addressing caregiver concerns about medications may improve adherence and ultimately decrease CLDP-related morbidities. Larger, prospective studies are needed to confirm these findings and determine which factors predict non-adherence. Pediatr Pulmonol. 2012; 47:283-291. (C) Wiley Periodicals, Inc.
引用
收藏
页码:283 / 291
页数:9
相关论文
共 50 条
  • [31] Management of infants with chronic lung disease of prematurity in Australasia
    Askie, LM
    Henderson-Smart, DJ
    Jones, RA
    EARLY HUMAN DEVELOPMENT, 2005, 81 (02) : 135 - 142
  • [32] THE CHANGING PATTERN OF CHRONIC LUNG-DISEASE OF PREMATURITY
    HYDE, I
    ENGLISH, RE
    WILLIAMS, JD
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1989, 64 (04): : 448 - 451
  • [33] Management of infants with chronic lung disease of prematurity in China
    Li, J
    Wei, KL
    EARLY HUMAN DEVELOPMENT, 2005, 81 (02) : 151 - 154
  • [34] Management of infants with chronic lung disease of prematurity in Chile
    Palomino, MA
    Morgues, M
    Martínez, F
    EARLY HUMAN DEVELOPMENT, 2005, 81 (02) : 143 - 149
  • [35] Inhaled nitric oxide reduces the magnitude of respiratory support in infants with chronic lung disease of prematurity.
    Kunig, A
    Solarin, K
    Haynes-Laing, A
    Bhutani, V
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S430 - S430
  • [36] CORTICOSTEROID RESPONSIVENESS IN CHRONIC LUNG-DISEASE OF PREMATURITY
    SCHICK, JB
    GOETZMAN, BW
    SMITH, LE
    WENNBERG, RP
    PEDIATRIC RESEARCH, 1981, 15 (04) : 680 - 680
  • [37] Lung function in school age children with chronic lung disease of prematurity
    Bar-Yishay, Ephraim
    Matyashchuk, Elena
    Prais, Dario
    Blau, Hannah
    Kaplan, Eytan
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [38] Chronic Obstructive Pulmonary Disease Illness And Medication Beliefs Are Associated With Medication Adherence
    Krauskopf, K.
    Federman, A. D.
    Kale, M. S.
    Sigel, K. M.
    Martynenko, M.
    O'Conor, R.
    Wolf, M. S.
    Leventhal, H.
    Wisnivesky, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [39] Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence
    Krauskopf, Katherine
    Federman, Alex D.
    Kale, Minal S.
    Sigel, Keith M.
    Martynenko, Melissa
    O'Conor, Rachel
    Wolf, Michael S.
    Leventhal, Howard
    Wisnivesky, Juan P.
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (02) : 154 - 161
  • [40] Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease
    Parker, Krystina
    Bull-Engelstad, Ingrid
    Aasebo, Willy
    von der Lippe, Nanna
    Reier-Nilsen, Morten
    Os, Ingrid
    Stavem, Knut
    HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 333 - 342